Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case.
Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T, Ijima M, Fujiwara M, Kaneshiro E, Ohashi T, Eto Y, Ishigaki K, Osawa M, Kyosen SO, Ida H. Kobayashi H, et al. Among authors: ida h. Mol Genet Metab. 2010 May;100(1):14-9. doi: 10.1016/j.ymgme.2010.01.015. Epub 2010 Feb 4. Mol Genet Metab. 2010. PMID: 20202878
The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.
Higuchi T, Kawagoe S, Otsu M, Shimada Y, Kobayashi H, Hirayama R, Eto K, Ida H, Ohashi T, Nakauchi H, Eto Y. Higuchi T, et al. Among authors: ida h. Mol Genet Metab. 2014 May;112(1):44-8. doi: 10.1016/j.ymgme.2014.02.012. Epub 2014 Mar 4. Mol Genet Metab. 2014. PMID: 24642446
Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.
Sato Y, Fujiwara M, Kobayashi H, Yoshitake M, Hashimoto K, Oto Y, Ida H. Sato Y, et al. Among authors: ida h. Mol Genet Metab Rep. 2015 Nov 8;5:94-97. doi: 10.1016/j.ymgmr.2015.10.014. eCollection 2015 Dec. Mol Genet Metab Rep. 2015. PMID: 28649551 Free PMC article.
Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy.
Miwa S, Watabe AM, Shimada Y, Higuchi T, Kobayashi H, Fukuda T, Kato F, Ida H, Ohashi T. Miwa S, et al. Among authors: ida h. Mol Genet Metab. 2020 Aug;130(4):262-273. doi: 10.1016/j.ymgme.2020.06.007. Epub 2020 Jun 24. Mol Genet Metab. 2020. PMID: 32631737
684 results